Caring for stage IB cancer of the cervix. Proposal for a protocol based on a review of the literature;Prise en charge du cancer du col utérin au stade IB. Proposition d'un protocole fondé sur une revue de la littérature

Gynecologie Obstetrique et Fertilite

Volumn 31, Issue 1, 2003, Pages 2-13

  Aubard, Y ^a   Genet, D ^a   Philippe, H J ^a  

^a DUPUYTREN UNIVERSITY HOSPITAL   (France)

Author keywords

Cervix cancer; Early stage

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; FLUOROURACIL; HYDROXYUREA;

CANCER STAGING; DIAGNOSTIC IMAGING; FEMALE; FEMALE FERTILITY; GENERAL ANESTHESIA; HUMAN; LAPAROSCOPIC SURGERY; LAPAROSCOPY; LAPAROTOMY; LUMBOAORTIC LYMPHADENECTOMY; LYMPH NODE METASTASIS; LYMPHADENECTOMY; LYMPHOGRAPHY; MAJOR CLINICAL STUDY; MULTIMODALITY CANCER THERAPY; NUCLEAR MAGNETIC RESONANCE IMAGING; PELVIS LYMPHADENECTOMY; PHYSICAL EXAMINATION; POSTOPERATIVE CARE; PROGNOSIS; RADICAL HYSTERECTOMY; REVIEW; SENSITIVITY AND SPECIFICITY; TUMOR VOLUME; UTERINE CERVICECTOMY; UTERINE CERVIX CANCER; VAGINAL HYSTERECTOMY;

EID: 0345269683     PISSN: 12979589     EISSN: 17696682     Source Type: Journal    
DOI: 10.1016/S1297-9589(02)00002-4     Document Type: Review

References (87)

1. Benedet J, Odicino F, Maisonneuve P, Severi G, Creasman W, Shepherd J, et al. Carcinoma of the cervix. J Epidemio Biostat 1998;3: 5-34.
2. Landoni F, Maneo A, Colombo A, Placa F, Milani R, Perego P, et al. Randomised study of radical surgery versus radiotherapy for STEG Ib-IIa cervical cancer. Lancet 1997;350:535-40.
3. FIGO. Modifications in the staging for stage I vulvar and stage I cervical cancer, Report of the FIGO committee on Gynecol Oncol. Int J Gynecol Obstet 1995;50:215-6.
4. Creasman WT. New gynecologic cancer staging (editorial). Gynecol Oncol 1995;58:157-8.
5. e édition. Saint-Etienne: Impression Dumas; 1998 (UICC, ed.).
6. Eifel PJ. Problems with the clinical staging of carcinoma of the cervix. Semin Oncol 1994;4:1-8.
7. Gerbaulet A, Kunkler IH, Kerr GR, Haie C, Michel G, Prade M. Combined radiotherapy and surgery: local control and complications in early carcinoma of the uterine cervix - the Villejuif experience, 1975-1984. Radiother Oncol 1992;23:66-73.
8. FIGO. Cancer commitee, Staging announcement. Gynecol Oncol 1986;25:383-5.
9. Lowrey GC, Mendenhall WM, Million RR. Stage IB or IIA-B carcinoma of the intact uterine cervix treated with irradiation: a multivariate analysis. Int J Radiat Oncol Biol Phys 1992;24:205-10.
10. Mendenhall WM, McCarty PJ, Morgan LS, Chafe WE, Million R. Stage IB or IIA-B carcinoma of the intact uterine cervix greater than or equal to 6 cm in diameter: is adjuvant extrafacial hysterectomy beneficial. Int J Radiat Oncol Biol Phys 1991;21:899-904.
11. Perez CA, Grisgsby PW, Nene SM, Camel HM, Galakatos A, Kao MS. Effect of tumor size on the prognosis of carcinoma of the uterine cervix treated with irradiation alone. Cancer 1992;69: 2796-806.
12. Lou H, Chen Y, Sun H. Prognostic factors affecting the results of surgical treatment of cervical cancer. Chung Hua Chung Liu Tsa Chih 1996;18:64-6.
13. Fyles A, Kirkbride P. Cervix uteri carcinoma. In: Hermanek P, Gospodarowicz MK, Henson DE, Hutter RVP, Sobin LH, editors. Prognostic factors in cancer. Berlin: Springer; 1995. p. 185-92.
14. Barillot I, Horiot JC, Pigneux J, Schraub S, Pourquier H, Daly N. Carcinoma of the intact uterine cervix treated with radiotherapy alone: a french cooperative study: update and multivariate analysis of prognostic factors. Int J Radiat Oncol Biol Phys 1997;58:969-78.
15. Stehman FB, Bundy BN, DiSaia PJ, Keys HM, Larson JE, Fowler WC. Carcinoma of the cervix treated with radiation therapy, I. A multivariate analysis of prognostic factors variables in the Gynecol Oncol Group. Cancer 1991;67:2776-85.
16. Morice P, Castaigne D, Pautier P, Rey A, Haie-Meder C, Leblanc M, et al. Interest of pelvic and paraaortic lymphadenectomy in patients with stage IB and II cervical carcinoma. Gynecol Oncol 1999;73:106-10.
17. Hricak H, Lacey CG, Sandles LG, Chang YC, Winkler ML, Stern JL. Invasive cervical carcinoma: comparison of MR imaging and surgical findings. Radiology 1988;166:623-31.
18. Burghardt E, Hofmann HM, Ebner F, Haas J, Tamussino K, Justich E. Magnetic resonance imaging in cervical cancer: a basis for objective classification. Gynecol Oncol 1989;33:61-7.
19. Burke TW, Heller PB, Hoskins WJ, Weiser EB, Nash JD, Park RC. Evaluation of the scalene lymph nodes in the primary and recurrent cervical carcinoma. Gynecol Oncol 1987;28:312-7.
20. Alvarez RD, Potter ME, Soong SJ, Gay FL, Hatch KD, Partridge EE. Rationale for using pathological tumor dimensions and nodal status to subclassify treated stage IB cervical cancer patients. Gynecol Oncol 1991;43:108-12.
21. Hacker NF. Cervical cancer. In: Wilkins LW, editor. Practical gynecologic oncology. Philadelphia: Berek J.S., Hacker N.F.; 2000. p. 345-406.
22. Hoskins WJ, Perez C, Young R. Gynecologic tumors. In: De Vita VT, Hellman S, Rosenberg SA, editors. Cancer principles and practice of oncology. 3rd ed. Philadelphia: Lippincott; 1989. p. 1099-161.
23. FNCLCC. Standards, options et recommandations. Cancers invasifs du col utérin, stades non-métastatiques. Paris: John Libbey; 1999 (Cancer FNCLCC, ed.).
24. Michel G, Morice P, Castaigne D, Leblanc M, Rey A, Duvillard P. Lymphatic spread of stage IB/II cervical carcinoma: anatomy and surgical implications. Obstet Gynecol 1998;91:360-3.
25. Pastner B, Sedlacek TV, Lovecchio JL. Para-aortic node sampling in small (3 cm or less) stage IB invasive cervical cancer. Gynecol Oncol 1992;44:53-4.
26. Gerbaulet A, Michel G, Haie-Maider C, Castaigne D, Lartigau E, Lhomme C. The role of low dose rate brachytherapy in the treatment of cervix carcinoma. Eur J Gynaecol Oncol 1995;16:461-75.
27. Childers JM, Hatch K, Surwit A. The role of laparoscopic lymphadenectomy in the management of cervical carcinoma. Gynecol Oncol 1992;47:38-43.
28. Querleu D. Laparoscopic para-aortic node sampling in gynecologic oncology: a preliminary experience. Gynecol Oncol 1993;49:24-9.
29. Dargent D, Ansquer Y, Mathevet P. Technical development and results of left extraperitoneal laparoscopic paraaortic lymphadenectompy for cervical cancer. Gynecol Oncol 2000;77:87-92.
30. Lanvin D, Elhage A, Henry B, Leblanc E, Querleu D, Delobelle-Deroide A. Accuracy and safety of laparoscopic lymphadenectomy: an experimental prospective randomized study. Gynecol Oncol 1997;67:83-7.
31. Possover M, Krause N, Plaul K, Kühne-Heid R, Schneider A. Laparoscopic para-aortic and pelvic lymphadenectomy: experience with 150 patients and review of the literature. Gynecol Oncol 1998;71:19-28.
32. Fowler JM, Carter JR, Carlson JW, Maslonkowski R, Byers LJ, Carson LF, et al. Lymph node yield from laparoscopic lymphadenectomy in cervical cancer: a comparative study. Gynecol Oncol 1993;51:187-92.
33. Rose PG, Adler LP, Rodriguez M, Faulhaber PF, Abdul-Karim FW, Miraldi F. Positron emission tomography for evaluating paraaortic nodal metastatsis in locally advanced cervical cancer before surgical staging: a surgicopathological study. J Clin Oncol 1999;17:41-5.
34. Lartigau E, Gerbaulet A, Haie-Meder C, Marsiglia H, Michel G, Prade M. Pretherapeutic evaluation of cancers of the uterine cervix in young women: are there specific prognostic factors? Bull Cancer/Radiothérapie 1994;81:413-7.
35. Meanwell CA, Kelly KA, Wilson S, Roginski C, Woodman C, Griffiths R. Young age as a prognosis factor in cervical cancer: analysis of population based data from 10 022 cases. Br Med J Clin Res Ed 1988;296:386-91.
36. Grogan M, Thomas GM, Melamed I, Wong FL, Pearcey RG, Joseph PK, et al. The importance of hemoglobin levels during radiotherapy for carcinoma of the cervix. Cancer 1999;86:1528-36.
37. Dische S. Radiotherapy and anaemia - the clinical experience. Radiother Oncol 1991;20(suppl. 1):35-40.
38. Bush RS, Jenkin RD, Allt WE, Beale FA, Bean H, Dembo AJ. Definitive evidence for hypoxic cells influencing cure in cancer therapy. Br J Cancer 1978;37:3026-306.
39. Eifel PJ. Early stage I adenocarcinoma of the uterine cervix: treatment results in patients with tumors < 4 cm in diameter. Gynecol Oncol 1991;41:199.
40. Kjorstad KE, Bond B. Stage IB adenocarcinome of the cervix: metastatic potential and patterns of dissemination. Am J Obstet Gynecol 1984;150:297.
41. DiSaia PJ, Creasman WT. Clinical Gynecologic Oncology. Fifth ed. St Louis: Mosby-Tear Book; 1997.
42. Lotocki RJ. Glassy cell carcinoma of the cervix: a bimodal treatment strategy. Gynecool Oncol 1992;44:254.
43. Boyce JG, Fruchter RG, Nicastri AD. Vascular invasion in stage I carcinoma of the cervix. Cancer 1984;53:1175-80.
44. Crissman JD, Makuch R, Budhraja M. Histopathologic grading of squamous cell carcinoma of the uterine cervix, An evaluation of 70 stage Ib patients. Cancer 1985;55:1590-6.
45. Van Nagell JR, Donaldson ES, Wood EG, Parker JC. The significance of vascular invasion and lymphocytic infiltration in invasive cervical cancer. Cancer 1978;41:228-34.
46. Delgado G, Bundy B, Zaino R, Sevin BU, Creasman WT, Major F. Prospective surgical-pathological study of disease-free interval in patients with stage IB squamous cell carcinoma of the cervix: a gynecologic oncology group study. Gynecol Oncol 1990;38:352-7.
47. Averette HE, Nguyen HN, Donato DM, Penalver MA, Sevin BU, Estape R. Radical hysterectomy for invasive cervical cancer: a 25-year prospective experience with the Miami technique. Cancer 1993;71:1422-37.
48. Obermain A, Warner C, Bilgi S, Speiser P, Kaider A, Reinthaller A. Tumor angiogenesis in stage IB cervical cancer: correlation of microvessel density with survival. Am J Obstet Gynecol 1998;178:314-9.
49. Duk JM, Groenier KH, De Bruijn HWA, Hollema H, Ten Hoor KH, Van der Zee AGJ. Pretreatment serum squamous cell carcinoma antigen: a newly identified prognosis factor in early stage cervical carcinoma. J Clin Oncol 1996;14:111-8.
50. Rose BR, Thompson CH, Simpson JM, Jarret CS, Elliott PM, Tattersall MHN. Human papillomavirus deoxyribonucleic acid as a prognostic indicator in early stage cervical cancer: a possible role for type 18. Am J Obstet Gynecol 1995;173:1461-8.
51. Lombard I, Vincent-Salomon A, Validire P, Zafrani B, De la Rochefordiére A, Clough K. Human papilloma genotype as a major determinant of the course of cervical cancer. J Clin Oncol 1998;16:2613-9.
52. Piver MS, Rutledge F, Smith JP. Five classes of extended hysterectomy for women with cervical cancer. Obstet Gynecol 1974;44:265-72.
53. Dargent D. A new future for Schauta's operation through pre-surgical retroperitoneal pelviscopy. Eur J Gynecol Oncol 1987;8:292-6.
54. Roy M, Plante M, Renaud MC, Tetu B. Vaginal radical hysterectomy versus abdominal radical hysterectomy in the treatment of early-stage cervical cancer. Gynecol Oncol 1996;62:336-9.
55. Sardi J, Vidaurreta J, Bermudez A, Di Paolo G. Laparoscopically assisted Schauta operation: learning experience at the gynecologic oncology unit, Buenos Aeres University Hospital. Gynecol Oncol 1999;75:361-5.
56. Wertheim E. The extended abdominal operation for carcinoma uteri (based on 500 operative cases). J Obstet Dis Women Children 1912; 64:132-69.
57. Shingleton HM. Primary surgical treatment of invasive cancer. In: Anonyme, editor. Cancer of the cervix. Philadelphia: JB Lippincott Compagny; 1995. p. 123-54.
58. Dargent D, Brun JL, Roy M, Mathevet P, Remy I. La trachélectomie élargie: une alternative à l'hystérectomie radicale dans le traitement des cancers infiltrants sur la face externe du col utérin. JOBGYN 1994;2:285-92.
59. Roy M, Plante M. Pregnancies after radical vaginal trachelectomy for early-stage cervical cancer. Am J Obstet Gynecol 1998;179:1491-6.
60. Covens A, Shaw P, Murphy J, DePetrillo D, Lickrish G, Laframboise S, et al. Is Radical trachelectomy a safe alternative to radical hysterectomy for patients with stage 1A-B carcinoma of the cervix? Cancer 1999;86:2273-9.
61. Cosin JA, Fowler JM, Chen MD, Paley PJ, Carson LF, Twiggs LB. Pretreatment surgical staging of patients with cervical carcinoma (the case for lymph node debulking). Cancer 1998;82:2241-8.
62. Hacker NF, Wain GV, Nicklin JL. Resection of bulky positive lymph nodes in patients with cervical carcinoma. Int J Gynecol Cancer 1995;5:250-6.
63. Downey GO, Potish RA, Adcock LL, Prem KA, Twiggs LB. Pretreatment surgical staging in cervical carcinoma: therapeutic efficacy of pelvic lymph node resection. Am J Obstet Gynecol 1989;160:1055-61.
64. Tod MC, Meredith WJ. Treatment of cancer of the cervix uteri - a revised "Manchester method". Br J Radiol 1953;26:252-7.
65. Tod MC, Meredith WJ. Dosage system for use in treatment of carcinoma of the cervix. Br J Radiol 1938;11:809-23.
66. International commission on radiation units and measurements. Dose and volume specification for reporting intracavitary therapy in gynecology. ICRU 1985.
67. Perez CA, Hoskins WJ, Perez CA, Yung RC. Principles and practice of Gynecol Oncol. Philadelphia: JB Lippincott Company; 1992.
68. Cunningham MT, Dunton CT, Corn B. Extended-field radiation therapy in early-stage carcinoma: survival and complications. Gynecol Oncol 1991;43:51-4.
69. Komaki R, Mattingly RF, Hoffman RG, Barber SW, Satre R, Greenberg M. Irradiation of para-aortic lymph node metastases from carcinoma of the cervix endometrium. Radiology 1983;147:245-8.
70. Morris M, Eifel PJ, Lu J, Grigsby PW, Levenback C, Stevens RE, et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med 1999;340:1137-43.
71. Keys HM, Bundy BN, Stehman FB, Muderspach LI, Chafe WE, Suggs CL, et al. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med 1999;340:1154-61.
72. Peters WA, Liu PY, Barrett R, Gordon W, Stock R, Berek JF, et al. Cisplatin, 5-Fluorouracil, plus radiation therapy are superior to radiation therapy as adjunctive therapy in high-risk, early stage carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy, Report of a phase III intergroup study. Gynecol Oncol 1999;72:443.
73. Landoni F, Zanetta GM, Buda A, Torri V, Lissoni A, Zola P, et al. Randomised multicentric phase II trial of neoadjuvant chemotherapy in the treatment of locally advanced squamous cell cervical cancer, Comparison of cisplatin, ifosfamide versus paclitaxel, cisplatin, ifosfamide. Eur J Gynaecol Oncol 2001;22(supp. 2001):35.
74. Landoni F, Maneo A, Villa A, dell'Anna T. Chemotherapy and conization for preserving fertility in stage IB1 cervical cancer. In: BenRafael Z, Shoham Z, Frydman R, editors. The second world congress on controversies in obstetrics gynecology & infertility. Paris: Mondozzi; 2001. p. 385-8.
75. Soutter P. Radical surgery or radiotherapy for stage Ib-IIa cervical cancer. Lancet 1997;350:532.
76. Buckley SL, Tritz DM, VanLe L, Higgins R, Sevin BU, Ureland FR, et al. Lymph node metastases and prognosis in patients with stage Ia2 cervical cancer. Gynecol Oncol 1996;63:4-9.
77. Aubard Y, Piver P, Pech JC, Galinat S, Teissier MP. Ovarian tissue cryopreservation and gynaecologic oncology. Eur J Obstet Gynecol Reprod Bio 2001;97:5-14.
78. Aubard Y, Poirot C, Piver P, Galinat S, Teissier MP. Are there indications for ovarian tissue cryopreservation? Fertil Steril 2001;76:414-5.
79. Haie-Meder C, Mlika-Cabane N, Michel G, Briot E, Gerbaulet A, Lhomme C, et al. Radiotherapy after ovarian transposition: ovarian function and fertility preservation. Int J Radiat Oncol Biol Phys 1993;25:419-24.
80. Chen NJ, Okuda H, Sekiba K. Recurrent carcinoma of the vagina following Okabayashi's radical hysterectomy for cervical cancer. Gynecol Oncol 1985;20:10-6.
81. Larson DM, Copeland LJ, Stringer CA, Gerhensen DM, Malone JM, Edwards CL. Recurrent cervical carcinoma after radical hysterectomy. Gynecol Oncol 1998;30:381-7.
82. Renaud MC, Plante M, Roy M. Combined laparoscopic and vaginal radical surgery in cervical cancer. Gynecol Oncol 2000;79:59-63.
83. Shigematsu Y, Nishiyama K, Masaki N, Inoue T, Miyata Y, Ikeda H. Treatment of carcinoma of the uterine cervix by remotely controlled afterloading intracavitary radiotherapy with high-dose rate: a comparative study with high-dose rate: a comparative study with a low-dose rate system. Int J Radiat Oncol Biol Phys 1983;9:351-6.
84. Patel FD, Sharma SC, Negi PS, Ghoshal S, Gupta BD. Low dose rate vs high dose rate brachytherapy in the treatment of carcinoma of the uterine cervix: a clinical trial. Int J Radiat Oncol Biol Phys 1994;28:335-41.
85. Orton CG, Seyedsadr M, Somnay A. Comparison of high and low dose rate remote afterloading for cervix cancer and the importance of fractionation. Int J radiat Oncol Biol Phys 1991;21:1425-34.
86. Whitney CW, Sause W, Bundy BN, Malfetano JH, Hannigan EV, Fowler WC, et al. Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a GOG and SOG study. J Clin Oncol 1999;17:1339-48.
87. Rose PG, Bundy BN, Watkins EB, Thigpen JT, Deppe G, Maiman MA, et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med 1999; 340:1144-53.